全文获取类型
收费全文 | 770篇 |
免费 | 40篇 |
国内免费 | 59篇 |
专业分类
儿科学 | 43篇 |
妇产科学 | 6篇 |
基础医学 | 42篇 |
口腔科学 | 13篇 |
临床医学 | 144篇 |
内科学 | 219篇 |
皮肤病学 | 17篇 |
神经病学 | 12篇 |
特种医学 | 229篇 |
外科学 | 32篇 |
综合类 | 27篇 |
预防医学 | 24篇 |
眼科学 | 8篇 |
药学 | 31篇 |
中国医学 | 2篇 |
肿瘤学 | 20篇 |
出版年
2022年 | 3篇 |
2021年 | 9篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 12篇 |
2017年 | 3篇 |
2016年 | 1篇 |
2015年 | 13篇 |
2014年 | 13篇 |
2013年 | 23篇 |
2012年 | 11篇 |
2011年 | 11篇 |
2010年 | 21篇 |
2009年 | 22篇 |
2008年 | 12篇 |
2007年 | 49篇 |
2006年 | 7篇 |
2005年 | 15篇 |
2004年 | 11篇 |
2003年 | 8篇 |
2002年 | 5篇 |
2001年 | 8篇 |
2000年 | 5篇 |
1999年 | 11篇 |
1998年 | 51篇 |
1997年 | 35篇 |
1996年 | 59篇 |
1995年 | 44篇 |
1994年 | 40篇 |
1993年 | 49篇 |
1992年 | 8篇 |
1991年 | 10篇 |
1990年 | 18篇 |
1989年 | 27篇 |
1988年 | 33篇 |
1987年 | 34篇 |
1986年 | 25篇 |
1985年 | 29篇 |
1984年 | 16篇 |
1983年 | 10篇 |
1982年 | 12篇 |
1981年 | 22篇 |
1980年 | 19篇 |
1979年 | 6篇 |
1978年 | 9篇 |
1977年 | 15篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1970年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有869条查询结果,搜索用时 15 毫秒
91.
AET White FRCS KG Davies FRCS S Anwar MB JW Neal MRCPath JA Vafidis FRCS 《International journal of clinical practice》1994,48(4):222-223
SUMMARY Intracranial tuberculoma has become a rarity. It remains a curable lesion that responds well to medical therapy. Although diagnosis in developed countries is often made only postoperatively, early and effective treatment can be instituted if a high index of suspicion is maintained and diagnostic criteria are looked for. A case is presented which illustrates the difficulties in reaching a diagnosis, and a review of the literature is given. 相似文献
92.
营养药理学--谷氨酰胺、n-3脂肪酸和精氨酸等简介 总被引:5,自引:2,他引:3
引言营养不良总是影响外科患者的预后,20世纪初就有人注意到伴有营养不良(以体重降低20%为依据)的消化性溃疡患者术后恢复较慢。后来几十年的研究证明,特殊营养素(如某些维生素和矿物质)缺乏能导致疾病,给予补充则可恢复健康。近年来研究发现,低蛋白血症等营养不良指标与并发症的发生率和死亡率相关。20世纪60年代至70年代的研究表明,对于严重烧伤儿童,只增加营养素(蛋白)的相对浓度而不增加总热卡摄入,可纠正免疫功能低下,提高生存率,改善患儿预后。谷氨酰胺、n-3脂肪酸和精氨酸对疾病的影响引起人们的特别关注,许多学者致力于研究这些营养… 相似文献
93.
94.
95.
PJ Smith ; TE Miller ; J Fraser ; JW Smith ; JR Svirbely ; S Rudmann ; PL Strohm ; M Kennedy 《Transfusion》1991,31(4):313-317
Four empirical studies were conducted for better understanding of the nature of problem-solving activities by medical technologists and medical technology students when performing antibody identification tasks. The results indicated the importance of strategies that ensure the collection of converging evidence, as these strategies protect against the fallibility of commonly used heuristics and against errors due to simple slips. The results also indicate that not only do students make significant numbers of errors, but so do practicing technologists. In one of the studies covering a 1-year period, for instance, a group of 16 technologists made a total of 41 errors in 1057 cases. On the basis of these findings, several alternatives are proposed to reduce errors. 相似文献
96.
Conflict between substitute decision makers (SDMs) and health care providers in the intensive care unit is commonly related to goals of treatment at the end of life. Based on recent court decisions, even medical consensus that ongoing treatment is not clinically indicated cannot justify withdrawal of mechanical ventilation without consent from the SDM. Cardiopulmonary resuscitation (CPR), similar to mechanical ventilation, is a life-sustaining therapy that can result in disagreement between SDMs and clinicians. In contrast to mechanical ventilation, in cases for which CPR is judged by the medical team to not be clinically indicated, there is no explicit or case law in Canada that dictates that withholding/not offering of CPR requires the consent of SDMs. In such cases, physicians can ethically and legally not offer CPR, even against SDM or patient wishes. To ensure that nonclinically indicated CPR is not inappropriately performed, hospitals should consider developing ‘scope of treatment’ forms that make it clear that even if CPR is desired, the individual components of resuscitation to be offered, if any, will be dictated by the medical team’s clinical assessment. 相似文献
97.
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation 总被引:2,自引:0,他引:2
Phillips GL; Wolff SN; Herzig RH; Lazarus HM; Fay JW; Lin HS; Shina DC; Glasgow GP; Griffith RC; Lamb CW 《Blood》1989,73(8):2086-2092
Twenty-six patients with progressive Hodgkin's disease after conventional chemotherapy received intensive chemoradiotherapy and autologous bone marrow transplantation (ABMT); 19 also received additional involved-field radiotherapy. Twenty-one patients [81%, 95% confidence intervals (CI) 61% to 94%] attained complete (n = 18) or partial responses. Ten patients (38%, 95% CI 20% to 59%) are disease- free a median of 4.5 years later (range 3.5 to 7.0 years), including seven patients with continuous complete responses. The likelihood of overall response was not significantly influenced by any clinical or treatment variable examined. However, there was a trend favoring patients with higher Karnofsky scores, and higher scores were associated with attainment of complete responses (P = .06 and P = .02, respectively, Mann-Whitney U test). Both higher Karnofsky scores and shorter durations of disease before transplantation were associated with improved survival in a stepwise Cox multivariate analysis. The chief cause of failure was progression at sites previously involved with Hodgkin's disease. No patient relapsed in the marrow, and two of three patients with a history of marrow involvement with Hodgkin's disease achieved durable complete responses after transplantation. These data suggest that inadequate pretransplant conditioning, and not the reinoculation of occult tumor cells in the autologous marrow, caused most relapses. Fatal treatment-related toxicity occurred in six patients. Three patients died of idiopathic interstitial pneumonitis; each had previously received local mediastinal irradiation before intensive chemoradiotherapy. Intensive chemoradiotherapy and ABMT produces durable responses in some patients with Hodgkin's disease incurable with conventional therapy. Use of such therapies at the first sign of failure with conventional chemotherapy and development of more effective conditioning regimens should further improve results. 相似文献
98.
99.
100.
Studies on levamisole--induced agranulocytosis 总被引:1,自引:0,他引:1
Thompson JS; Herbick JM; Klassen LW; Severson CD; Overlin VL; Blaschke JW; Silverman MA; Vogel CL 《Blood》1980,56(3):388-396
Widespread clinical trials of leavo-tetramisole (levamisole) as an immunopotentiating agent in rheumatoid arthritis, metastatic carcinoma, and immunodeficiency states have been complicated by agranulocytosis (AGC) in 2.5%-13% of patients. Other than a relationship with prolonged high dosage, very little is known regarding the pathogenesis of levamisole-induced AGC. Whereas leukoagglutination was negative, fluorochromatic microgranulocytotoxicity (GCY) tests were positive with serum from 10 of 10 acutely neutropenic patients. The antibody was IgM, reacted with 100% of unrelated granulocytes, but not with T or B lymphocytes. Some sera also reacted with monocytes and the myeloid cell line, K-562. Tests for antigen-antibody complexes or cold autoantibodies were negative. Although clinical evidence strongly suggests a haptene (drug) mechanism, in vitro mixing experiments were also negative. An alternative choice parallels the model of aldomet- induced Coombs'-positive hemolytic anemia. Finally, GCY first became positive 2-3 mo prior to the onset of AGC on two patients, suggesting the possibility of identifying those at risk well before the onset of neutropenia. 相似文献